TRAP-6 (2-6) is a truncated peptide segment used to examine thrombin receptor-activating sequences. Its compact structure enables studies of minimal motifs required for receptor engagement. Researchers apply it to assess peptide-receptor docking behavior. The molecule supports modeling of protease-activated signaling pathways.
CAT No: C0124
CAS No:141136-84-7
Synonyms/Alias:FLLRN;141136-84-7;Phe-leu-leu-arg-asn;Phenylalanyl-leucyl-leucyl-arginyl-asparagine;H 8325;H-8325;(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-oxobutanoic acid;L-Asparagine, N2-(N2-(N-(N-L-phenylalanyl-L-leucyl)-L-leucyl)-L-arginyl)-;DTXSID00930999;HY-P5359;TRAP-6 (2-6) trifluoroacetate salt;FT110302;H-Phe-Leu-Leu-Arg-Asn-OH; H-FLLRN-OH;CS-0882543;L-Asparagine,L-phenylalanyl-L-leucyl-L-leucyl-L-arginyl-;(2S,5S,8S,11S,14S)-14-amino-2-(2-amino-2-oxoethyl)-5-(3-guanidinopropyl)-8,11-diisobutyl-4,7,10,13-tetraoxo-15-phenyl-3,6,9,12-tetraazapentadecan-1-oic acid;N-(2-{[2-({2-[(2-Amino-1-hydroxy-3-phenylpropylidene)amino]-1-hydroxy-4-methylpentylidene}amino)-1-hydroxy-4-methylpentylidene]amino}-5-carbamimidamido-1-hydroxypentylidene)-4-iminohomoserine;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More